Hyperkeratotic chronic tinea pedis treated with neticonazole cream

International Journal of Dermatology

Volumn 35, Issue 5, 1996, Pages 371-373

  Tsuboi, Ryoji ^b   Matsumoto, Tadahiko ^b   Ogawa, Hideoki ^a   Kuriya, N ^b   Yoshiike, T ^b   Nishiyama, C ^b   Arase, S ^b   Asada, Y ^b   Fujimoto, N ^b   Fukuda, M ^b   Fukumoto, T ^b   Hamada, T ^b   Horinosono, H ^b   Horio, T ^b   Ichihashi, M ^b   Iida, T ^b   Ikeda, M ^b   Ishido, I ^b   Iwasawa, U ^b   Kawahira, K ^b   Kawashima, M ^b   Kobayashi, H ^b   Kodama, H ^b   Mihara, M ^b   Nagashima, M ^b   Nagayama, M ^b   Nakagawa, K ^b   Natsume, T ^b   Nishikawa, Y ^b   Shiohara, T ^b   Shirai, T ^b   Suzuki, H ^b   Takemura, H ^b   Tanabe, E ^b   Taneda, A ^b   Tsuji, T ^b   Uchida, K ^b   Ueda, M ^b   Unno, K ^b   Urano, Y ^b   Urashima, R ^b   Utsunomiya, M ^b   Yamamoto, K ^b   Yamashina, Y ^b   more..

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NETICONAZOLE;

ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTACT DERMATITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HYPERKERATOSIS; MAJOR CLINICAL STUDY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; TINEA PEDIS; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ANTIFUNGAL AGENTS; CHRONIC DISEASE; COLONY COUNT, MICROBIAL; ERYTHEMA; FEMALE; HUMANS; IMIDAZOLES; KERATOSIS; MALE; MYCOLOGY; OCCLUSIVE DRESSINGS; OINTMENTS; PRURITUS; TINEA PEDIS; TRICHOPHYTON;

EID: 0029977134     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4362.1996.tb03644.x     Document Type: Article

References (9)

1. Ogawa M, Matsuda H, Eto H, et al. Synthesis and antifungal activities of a series of (1,2-disubstituted vinyl) imidazoles. Chem Pharm Bull 1991; 39:2301-2307.
2. Asaoka T, Kawahara R, Iwasa A, et al. Antifungal activity of SS717, a new imidazole antimycotic. I. In vitro antimicrobial activity. Chemotherapy 1990; 38:753-768.
3. Maebashi K, Hiratani T, Uchida K, et al. In vitro antifungal activity of SS717, a new imidazole antimycotic. Jpn J Med Mycol 1990; 31:333-342.
4. Maebashi K, Hiratani T, Asagai Y, et al. Studies on the mechanism of antifungal action of a new imidazole antimycotic SS717. Jpn J Med Mycol 1990; 31:343-354.
5. Kagawa S, Nishikawa T, Takahashi H, et al. Neticonazole (SS717): clinical evaluation of its activities. In: Yamaguchi H, Kobayashi GS, Takashashi H, eds. Recent progress in antifungal chemotherapy. New York: Marcel Dekker, 1992:113-123.
6. Asaoka T, Kawahara R, Iwasa A, et al. Antifungal activity of SS717, a new imidazole antimycotic. II. Therapeutic effect and protective effect of pretreatment on experimental dermatophytosis in guinea pigs. Chemotherapy 1990; 38:769-779.
7. Yano K, Iwasa A, Numata H. Studies on the metabolic fate of neticonazole: absorption, distribution and excretion in rats and guinea pigs after single dermal application. Yakubutsudotai 1991; 6:553-566.
8. Kagawa S, Takahashi S, Takahashi H, et al. Clinical evaluation of SS717 cream in the treatment of dermatomycosis: a randomized comparative study with bifonazole cream as control. Kisotorinsho 1991; 25:2411-2442.
9. Savin R, Atton AV, Bergstresser PR, et al. Efficacy of terbinafine 1% cream in the treatment of moccasin-type tinea pedis: results of placebo-controlled multicenter trials. J Am Acad Dermatol 1994; 30:663-667.